PRRX1–NCOA1 ‐rearranged fibroblastic tumour: a clinicopathological, immunohistochemical and molecular genetic study of six cases of a potentially under‐recognised, distinctive mesenchymal tumour-Reference-Cited by-同舟云学术

PRRX1–NCOA1 ‐rearranged fibroblastic tumour: a clinicopathological, immunohistochemical and molecular genetic study of six cases of a potentially under‐recognised, distinctive mesenchymal tumour

Published:2021-09-03 Issue:6 Volume:79 Page:997-1003
ISSN:0309-0167
Container-title:Histopathology
language:en
Short-container-title:Histopathology

Author:

Dermawan Josephine K¹^ORCID,Azzato Elizabeth M¹,Jebastin Thangaiah Judith²,Gjorgova‐Gjeorgievski Sandra¹,Rubin Brian P¹,Folpe Andrew L²^ORCID,Agaimy Abbas³^ORCID,Fritchie Karen J¹

Affiliation:

1. Robert J. Tomsich Pathology and Laboratory Medicine Institute Cleveland Clinic Cleveland OHUSA

2. Department of Laboratory Medicine and Pathology Mayo Clinic Rochester MN USA

3. Institute of Pathology University Hospital Erlangen Erlangen Germany

Publisher

Wiley

Subject

General Medicine,Histology,Pathology and Forensic Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/his.14454

Reference28 articles.

1. Fusion of the AHRR and NCOA2 genes through a recurrent translocation t(5;8)(p15;q13) in soft tissue angiofibroma results in upregulation of aryl hydrocarbon receptor target genes